Fenella K S Welsh
Overview
Explore the profile of Fenella K S Welsh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parmar K, OReilly D, Valle J, Braun M, Malcomson L, Jones R, et al.
BMJ Open
. 2023 Mar;
13(3):e059369.
PMID: 36997247
Introduction: Liver resection is the only curative treatment for colorectal liver metastases (CLM). Resectability decision-making is therefore a key determinant of outcomes. Wide variation has been demonstrated in resectability decision-making,...
2.
Welsh F, Walsh C, Chandrakumaran K, Rathnaweera W, Roy A, Needham J, et al.
HPB (Oxford)
. 2022 Oct;
25(1):63-72.
PMID: 36253269
Background: Routine chemical venous thromboembolism (VTE) prophylaxis for liver surgery remains controversial, and often delayed post-operatively due to perceived bleeding risk. This study asked whether patients undergoing hepatectomy for colorectal...
3.
Wong-Lun-Hing E, M van Dam R, Welsh F, Wells J, John T, Cresswell A, et al.
HPB (Oxford)
. 2013 Oct;
16(7):601-9.
PMID: 24151899
Objectives: There is debate concerning the best mode of delivery of analgesia following liver resection, with continuous i.m. infusion of bupivacaine (CIB) plus patient-controlled i.v. analgesia (PCA) suggested as an...
4.
Knowles B, Welsh F, Chandrakumaran K, John T, Rees M
HPB (Oxford)
. 2012 Apr;
14(5):298-309.
PMID: 22487067
Background: Neoadjuvant chemotherapy for colorectal liver metastases (CRLM) reduces the accuracy of liver imaging which may understage patients pre-operatively. Retrospective review of a prospective database to determine whether liver-specific magnetic...
5.
Habib M, Cresswell A, Chandrakumaran K, Welsh F, John T, Rees M
Dig Surg
. 2012 Mar;
29(1):18-22.
PMID: 22441615
Background: Inflow control prior to transection for right hepatectomy may be achieved either by dissection and ligation of the individual hilar structures outside of the liver (EHD) or by mass...
6.
Rees J, Blazeby J, Fayers P, Friend E, Welsh F, John T, et al.
J Clin Oncol
. 2012 Mar;
30(12):1364-70.
PMID: 22430276
Purpose: Hepatic resection of colorectal carcinoma (CRC) liver metastases is increasing, but evidence for the impact of surgery on patient-reported outcomes (PROs) is limited. This study aimed to describe comprehensively...
7.
Welsh F, Tekkis P, John T, Rees M
HPB (Oxford)
. 2010 Jul;
12(3):188-94.
PMID: 20590886
Background: There is no prospective randomized data comparing laparoscopic to open hepatectomy. This study compared short- and long-term outcomes in patients undergoing hepatectomy for colorectal metastases (CRM), who were suitable...
8.
Cresswell A, Welsh F, Rees M
HPB (Oxford)
. 2010 May;
11(7):533-40.
PMID: 20495704
Background: Despite a growing body of evidence reporting the deleterious mechanical and oncological complications of biopsy of hepatic malignancy, a small but significant number of patients undergo the procedure prior...
9.
Cresswell A, Welsh F, John T, Rees M
HPB (Oxford)
. 2009 Oct;
11(6):493-8.
PMID: 19816613
Background: Control of hepatic inflow is a key manoeuvre during right hepatectomy and has traditionally been achieved by extrahepatic dissection of the component right portal inflow structures at the hepatic...
10.
Welsh F, Tekkis P, John T, Rees M
Dig Surg
. 2009 Feb;
25(6):406-12.
PMID: 19212112
Background/aims: Hepatic resection for colorectal liver metastases offers patients the best chance of long-term survival. Survival rates after resection range from 25 to 60%. Predictive models may risk-stratify patients and...